In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
All content for ASSFN Podcast is the property of ASSFN and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
SCS for Painful Diabetic Neuropathy with Dr. Erika Petersen
ASSFN Podcast
40 minutes
2 years ago
SCS for Painful Diabetic Neuropathy with Dr. Erika Petersen
In this episode, co-hosts Danika Paulo, Tessa Harland and Robert Ziechmann meet with guest speaker, Dr. Erika Petersen to discuss her work on spinal cord stimulation for painful diabetic neuropathy. Dr. Petersen is the Director of Functional and Restorative Neurosurgery at University of Arkansas Medical Sciences and recently published an article in JAMA on SCS for PDN. We discuss indications for this surgery, patient outcomes and experiences, unexpected findings, longer term follow up and how...
ASSFN Podcast
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
